Skip to main content
Sage Choice logoLink to Sage Choice
. 2025 Aug 26;39(12):983–996. doi: 10.1177/15459683251363241

Brain Oscillatory Modes as a Proxy of Stroke Recovery

Sylvain Harquel 1,2,3,, Andéol Cadic-Melchior 1,2,, Takuya Morishita 1,2, Lisa Fleury 1,2, Martino Ceroni 1,2, Pauline Menoud 1,2, Julia Brügger 1,2, Elena Beanato 1,2, Nathalie H Meyer 4, Giorgia G Evangelista 1,2, Philip Egger 1,2, Dimitri Van de Ville 5,6, Olaf Blanke 4,9, Silvestro Micera 7,8, Bertrand Léger 10, Jan Adolphsen 11, Caroline Jagella 12, Andreas Mühl 10, Christophe Constantin 13, Vincent Alvarez 13, Philippe Vuadens 10, Jean-Luc Turlan 10, Christophe Bonvin 13, Philipp J Koch 1,2,14, Maximilian J Wessel 1,2,15, Friedhelm C Hummel 1,2,16,
PMCID: PMC12686178  PMID: 41273103

Abstract

Background

Stroke is the leading cause of long-term disability, making the search for successful rehabilitation treatment one of the most important public health issues. A better understanding of the neural mechanisms underlying impairment and recovery is critical for optimizing treatments. Objective: We studied the longitudinal changes in brain oscillatory modes, linked to GABAergic system activity, and determined their importance for residual upper-limb motor functions and recovery.

Methods

Transcranial Magnetic Stimulation (TMS) was combined with scalp Electroencephalography (EEG) to analyze TMS-induced brain oscillations in a cohort of 66 stroke patients in the acute (N = 60), early (N = 48), and late subacute stages (N = 37).

Results

A data-driven parallel factor analysis (PARAFAC) approach to tensor decomposition extracted brain oscillatory modes, which significantly evolved longitudinally across stroke stages (permutation tests, pBonf < 0.05). Notably, the observed decrease of the α-mode, known to be linked with GABAergic system activity, was mainly driven by the recovering patients and was supportive of stroke recovery at the group level (Bayesian Kendall correlation, moderate to strong statistical evidence).

Conclusions

Overall, longitudinal evaluation of brain modes provides novel insights into functional reorganization of brain networks after a stroke. Notably, we propose that the observed α-mode decrease could correspond to a beneficial disinhibition toward the late subacute stage that fosters plasticity and facilitates recovery. These results confirm the relevance of future individual and direct monitoring of post-stroke modulations in inhibitory system activity, with the ultimate goal of designing electrophysiological biomarkers and refining therapies based on personalized neuromodulation.

Keywords: stroke, motor recovery, GABAergic disinhibition, α oscillations, TMS-EEG

Introduction

Stroke is the leading cause of motor disability in the adult population. The exact mechanisms underlying motor impairment and recovery are the targets of a relentless search, 1 but have yet to be elucidated in detail. Mechanistic knowledge is critical for designing and optimizing future patient-tailored rehabilitation protocols, in contrast to the current “one-size-fits-all” strategy adopted with limited success. 2 Among the proposed mechanisms, the role of the inhibitory system within the ipsilesional hemisphere has been suggested to be crucially relevant for the course of stroke recovery.3,4 Indeed, modulation of inhibition processes can be either beneficial or detrimental for recovery, depending on its direction (increase or decrease) and exact timing. While an increase of the gamma-aminobutyric acid (GABAergic) system activity is beneficial for limiting excitotoxic cell death in the hyper-acute stage, its lasting is detrimental and the presence of a disinhibition phase in later stages is instead favorable for fostering structural plasticity. 4 However, such phenomena have so far only been examined in animal models or small cohorts of mildly impaired patients.3,5,6 In the present work, we monitored it longitudinally in a cohort of stroke patients, by focusing on brain α oscillations induced by non-invasive cortical stimulation, taking advantage of the coupling between scalp electroencephalography (EEG) and transcranial magnetic stimulation (TMS).

TMS-EEG offers the unique opportunity to directly probe the properties of the neuronal electrophysiological activity. It inherits both from the causal inference 7 and the spatial resolution of TMS, 8 and from the temporal resolution of EEG, which allows to directly study neuronal oscillations. Since TMS pulses mainly act as a phase reset on neural oscillators, 9 this tool allows to better characterize the brain dynamics, that is, evoked neural oscillatory activity, of an area.10,11 Such readouts might be markers of functional reorganization processes that enable motor recovery, especially among the thalamocortical networks to which this technique is sensitive. 11 Focusing on evoked—instead of induced—oscillations excludes nonstationary brain activity,9,12 thus eliminating all sources of variability regarding oscillation latency and phase from one stimulation to another. 9 In a seminal study with healthy subjects, Premoli et al 13 explored TMS-induced oscillations over the primary motor cortex (M1) and found specific patterns of oscillations in the α and ß bands. Furthermore, by investigating changes induced by GABAergic drugs, the authors revealed a link between these patterns and the modulation of the GABAergic inhibitory system activity, which is of particular interest in the context of this study.

Recent studies proposed the use of a data-driven approach, the parallel factor analysis (PARAFAC), 14 capable of reducing the complexity inherent to TMS-induced oscillations datasets, which are multidimensional (3-5D), into a simpler collection of parsimonious and unique components, or modes.15,16 Applied on TMS-EEG datasets, it allowed to extract 3 to 4 brain oscillatory modes in M1 that were physiologically meaningful.15,16 These modes did not overlap in frequency; instead, each was primarily driven by one main oscillatory pattern in the θ, α, or β band, each related to a specific mechanism. The study of the mode associated with late TMS-induced α oscillations enables the monitoring of the evolution of inhibitory processes throughout the course of post-stroke motor recovery, since variations within this band are linked with functional inhibitory processes17 -20 mediated by the GABAergic system, though this neurotransmitter was also found to modulate faster β rhythms. 13

In the present study, we sought to elucidate the mechanisms underlying motor impairment and recovery after stroke by applying this powerful method in a large stroke cohort evaluated longitudinally from the acute to the late subacute stage, in the framework of the TiMeS project. 21 The present work complements the study of TMS-evoked responses, 22 the results of which will be put into perspective with those of the present study. Here, we specifically studied the changes in brain oscillatory modes unveiled from TMS-induced oscillations and determined their importance for residual motor functions and recovery.

Materials and Methods

This work is part of the TiMeS prospective cohort study of stroke cases, a detailed description of which is provided in our previous work,21,22 and in the Supplemental Material (SM).

Study Design

TMS-induced oscillations and behavior were assessed at 3 different time points, 1 week (referred to here as “acute stage,” A), 3 weeks (“early subacute stage,” ESA), and 3 months poststroke (“late subacute stage,” LSA, Figure 1(A)), on the same cohort of 66 patients previously described in Harquel et al 22 (see below and Table S1 for patients’ characteristics), after being admitted at the Cantonal Hospital in Sion, Switzerland. Additionally, in order to validate and replicate the PARAFAC approach on TMS-EEG data, 19 healthy young adults (age: 26.9 ± 2.9 years, 9 females) and 15 healthy older adults (aged-matched with patients, age: 67 ± 5 years, 11 females) were recruited and underwent a single TMS-EEG recording session at the TMS platforms of UPHUMMEL lab (Geneva and Sion, Switzerland). The study was conducted in accordance with the Declaration of Helsinki and was approved by Cantonal Ethics Committee Vaud, Switzerland (project number: 2018-01355). Written informed consent was obtained from all participants. This study is reported in compliance with STROBE guidelines. 23 The data related to this article are available upon reasonable request to the corresponding author.

Figure 1.

Panel A depicts TMS-EEG protocol design over different stroke stages; Panel B shows signal processing for oscillation maps; Panel C illustrates PARAFAC tensor decomposition for data analysis.

Protocol design and main data processing pipeline. (A). Protocol design including 3 TMS-EEG sessions (referred to as the acute, early subacute, and late subacute stages, respectively). (B). Signal processing pipeline for computing induced oscillation maps. For each patient and channel, the evoked activity was removed from the clean signal prior to the time-frequency (TF) transform. Each TF map was z transformed before averaging across trials. (C). Tensor decomposition using the PARAFAC approach. Induced oscillation maps were compiled into a tensor, with the patient and stroke stages as the 4th and 5th dimensions, respectively, and decomposed using the PARAFAC algorithm. This decomposition led to several components, or modes, whose weights are represented in the space (topography), frequency, time, patient, and stroke-stage dimensions, from left to right.

Patient Population

A total of 76 stroke patients were initially enrolled in the study following their admission to the Cantonal Hospital in Sion, Switzerland. Of these, 66 patients (mean age: 68.2 ± 13.2 years; 18 females) were included in the analysis, having undergone TMS-EEG recordings in at least one session (refer to Fig. S1 and Table S1 for the screening flow chart and the patient characteristics). Patients with first-ever or recurrent ischemic or hemorrhagic strokes were included. All patients received standard post-stroke therapy, including physiotherapy and occupational therapy, as defined by the guidelines of the clinical centers. Overall, TMS-EEG recordings were performed in 60 acute, 48 early and 37 late subacute patients. Among them, 27 patients completed assessments at all 3 time points, while 52 patients completed assessments at least twice. Specifically, 43 patients completed assessments at least in the acute and early subacute stages, 33 patients completed assessments at least in the acute and late subacute stages, and 30 patients completed assessments at least in the early and late subacute stages (Fig. S1A). Not all patients completed every session due to time constraints with clinical evaluations, patient unavailability, COVID-19 pandemic or the introduction of an exclusion factor, such as benzodiazepine intake. Moreover, the protocol, which included a battery of clinical, behavioral and neuroimaging recordings at each time point, was quite extensive and might be one reason of the withdrawal of patients from some of the experimental sessions. All the patients went through the protocol without reporting any adverse effects.

Inclusion and Exclusion Criteria

The inclusion criteria were as follows: older than 18 years of age, no contraindications for MRI or TMS, and (for the patient group) motor deficits of the upper limb. The exclusion criteria included cognitive inability to provide informed consent, history of seizures, pregnancy, severe neuropsychiatric or medical diseases, regular use of narcotic drugs or medication that significantly interact with TMS, implanted medical electronic devices or ferromagnetic metal implants incompatible with MRI or TMS, and the request not to be informed in case of incidental findings.

TMS-EEG Analysis

The analysis methodology used in this study was adapted from Tangwiriyasakul et al, 15 in which the PARAFAC tensor decomposition approach was applied to the preprocessed TMS-EEG data of our previous work. 22 This work adhered to recent guidelines for TMS-EEG acquisition and data processing, with the exception of the presence of a realistic sham stimulation condition.

Induced Oscillations

Induced oscillations were computed in MATLAB using the Fieldtrip toolbox 24 (Figure 1(B)). First, the TMS-evoked potentials (TEPs) were computed by averaging all trials and were then individually subtracted from the signal in each trial to filter out evoked activity. Then, the time-frequency (TF) map of each corrected trial was computed using a multitapers approach. The signal from the −500 to +1000 ms time window (10-ms step) was convoluted with Hanning tapers ranging from 7 to 40 Hz (1-Hz step), with a width of 3.5 cycles per window. For each electrode and trial, the resulting power time series was normalized using the z-score against baseline (−200 to −50 ms), before being averaged across trials to obtain the final TF maps. Prior to tensor definition, all the TF maps were flipped as needed so that the ipsilesional hemisphere was defined as the left for all patients.

PARAFAC Tensor Decomposition

Five different tensors were constructed as follows: the first tensor focused on the A stage (4D: electrode × frequency × time × patient), while the second to the fifth tensors gathered the induced oscillations across stroke stages (A vs. ESA stage, A vs. LSA stage, ESA vs. LSA stage, and from A to LSA stage; 5D: electrode × frequency × time × patient × stroke stage) (Figure 1(C)). For each tensor, the TF maps were cropped between +40 and +750 ms to prevent missing values from boundary effects, resulting in a size of 62 × 34 × 70 for the first 3 dimensions. The fourth-dimension size was equal to the number of patients included at the A stage (60), the A and ESA or LSA stages (43 or 33 respectively), the ESA and LSA stages (30), and all stages (27). Tensor decomposition was performed using the N-way toolbox (Rasmus Bro, 2024; https://www.mathworks.com/matlabcentral/fileexchange/1088-the-n-way-toolbox) using the non-negativity constraint to all dimensions.

Statistical Analysis

Differences between stroke stages when decomposing the 5D tensors were assessed using the same permutation-based approach proposed in Tangwiriyasakul et al 15 (see SM). The link between patient weights (data in the 4th dimension) within the extracted modes and motor scores for each stroke stage and change ratios between stroke stages (see SM) was explored using the Bayesian equivalent of nonparametric Kendall correlation and partial correlation testing using JASP software (JASP Team—2023). The weights of each extracted mode were compared with the initial motor scores in the A stage and to the change ratio between stroke stages. The selection of nonparametric correlation tests was justified by the non-normality of the distributions of motor scores and change ratio between stroke stages, as indicated by Shapiro-Wilk tests (all P < .01). The default values proposed within the JASP framework were used to keep the priors regarding effect sizes relatively large. Correlation values were reported using the 95% confidence interval of Kendall’s τ, while the statistical evidence of the tests was reported using Bayes factors (BF10) and the cutoff values defined by Jeffreys, 25 for interpretation.

Results

Clinical Outcome

Overall, the patients recovered from the acute to the late subacute stage at the group level (N = 66), as indicated by the significant difference in Fugl-Meyer Assessment (FM) of the upper extremity (FM-UE-total, see SM) scores across stroke stages (Kruskal-Wallis, χ2(2) = 11.079, P = .004), with a significant increase from 46.8 ± 19 points in the acute stage to 55.1 ± 12 points in the subacute stage (Table S1). Figure 2 shows the significant increase of FM-UE-total score distributions across stroke stages for the whole cohort (N = 66), the recovering group (N = 40 ; χ2(2) = 18.83, P < .001), and for the subsets of recovering patients (N = 17; χ2(2) = 9.48, P = .009) and patients that fulfilled the criterion of minimum clinically important difference (MCID+, N = 12 ; χ2(2) = 8.39, P = .015) included in the full longitudinal analysis, that is, who completed all TMS-EEG sessions (see Figure 3(A) and S6). Patients were considered as recovering and as MCID+ if the change in FM-UE-total was greater than 1 and 6 points from the acute to the subacute stages respectively. 26 The level of initial motor impairment in the acute stage of the 27 patients included in the full longitudinal analysis (FM-UE total = 50 ± 16) did not significantly differ from that of the 33 patients who missed at least one follow-up (FM-UE total = 46 ± 20), minimizing the risk of bias due to sample attrition (Mann–Whitney U = 471, P = 0.708).

Figure 2.

Upper-limb motor impairment evolution. From left to right: FM-UE-total score distributions significantly increased across stroke stages for the whole cohort (N = 66), the recovering group (N = 40), and for the subsets of recovering patients (N = 17) and patients that fulfilled the criterion of minimum clinically important difference (MCID+, N = 12) included in the full longitudinal analysis (see text).

Upper-limb motor impairment evolution. From left to right: FM-UE-total score distributions significantly increased across stroke stages for the whole cohort (N = 66), the recovering group (N = 40), and for the subsets of recovering patients (N = 17) and patients that fulfilled the criterion of minimum clinically important difference (MCID+, N = 12) included in the full longitudinal analysis (see text).

Figure 3.

The image depicts brain oscillatory modes in acute and subacute stroke patients, with PARAFAC decomposition of 4D tensor of TMS-induced oscillations in acute stroke patients and a longitudinal 5D tensor in all patients.

Brain oscillatory modes in acute stroke patients and their modulation toward subacute stages. (A) PARAFAC decomposition of the 4D tensor of the TMS-induced oscillations in acute stroke patients. Modes are sorted by row according to their main frequency peak, from low frequencies (1/f spectral trend, blue) and α (8 Hz, red) to β (15 Hz, green) frequency bands (top to bottom). Each column depicts the relative weights (from 0 to maximum) of each mode in the space, frequency, time, and patient dimensions (from left to right). The mode frequency peak is highlighted in color on the y-axis. Data were flipped for patients whose lesion was located on the right hemisphere so that the ipsilesional side was the left side. (B) PARAFAC decomposition of the longitudinal 5D tensor in all patients. The modes are represented identically, except for the addition of a fifth dimension representing the stroke stage (right). The asterisk and colored lines indicate significant effects of the pairwise comparisons of the stroke stages within the 1/f (blue lines) and α (red lines) modes for the acute (A) versus late subacute (LSA) stages and the early subacute (ESA) versus late subacute (LSA) stages (permutation test, pBonf < 0.05, see Statistical analysis).

Brain Oscillatory Modes in Acute Stroke Patients

Figure 3(A) shows the induced oscillatory modes obtained after the 4D tensor decomposition in A patients. Overall, the decomposition allowed us to identify 3 modes that were similar to those found on healthy young and older participants (see SM & Fig. S2 & S3), and to those previously reported in the literature.15,16 The first mode was mainly driven by low frequencies, and was characterized by the typical 1/f spectral trend of aperiodic activity, mostly located over the stimulation site. The second mode converged on the late parieto-occipital α waves (8-10 Hz peak for A patients and healthy controls) that emerged over time starting 150 to 200 ms after stimulation. The third mode mainly focused on central sensorimotor β waves. The exact peak frequencies tended to differ among the 3 groups: A patients presented 1 peak at 15 Hz, while healthy young adults showed 2 peaks at 7 and 21 Hz, and older adults showed 1 peak at 19 Hz (see Fig. S2).

Evolution of Brain Oscillatory Modes over the Time Course of Recovery

The results of the decomposition of the 5D tensors including all stroke stages (A, ESA and LSA) are presented in Figure 3(B). Interestingly, the mode weights were significantly modulated across stroke stages (pBonf < 0.05, see Fig. S4 for detailed results). This change was specific to 1/f and α-band modes that significantly differed from the A and the ESA stages to the LSA stage with opposite directions. While the relative weight of the α-band mode was stable at the ESA stage before significantly decreasing at the LSA stage, the aperiodic mode modulated in the opposite direction with a significant increase at the LSA stage. The changes between these 2 modes were not correlated but were mainly driven by different subgroups of patients, as shown by the lack of statistical evidence for a link between the weighting of patients in the α and 1/f mode (see Fig. S5 and SM). Overall, the changes were much stronger at the LSA stage, which was confirmed in larger groups of patients by pairwise comparisons between stroke stages: no change was found for any of the modes when comparing the A to the ESA stage (Figure 4(A)), whereas a strong increase and decrease in the 1/f and α-band modes, respectively, was found toward the LSA stage (pBonf < 0.05, Figure 4(B) and (C)). Finally, no significant modulation of the β-band mode through stroke stages was found in any of the tensor decompositions.

Figure 4.

Evolution of brain oscillatory modes from acute to subacute stages. (A) Results of a 5D tensor decomposition sorted by bands. Significant effects of pairwise comparisons of the stroke stages are marked.

Evolution of brain oscillatory modes from acute to subacute stages. (A) PARAFAC decomposition of the 5D tensor in all patients. The modes are sorted by peak frequency, from 1/f (blue) and α (red) to β (green) bands. Each column depicts the relative weights (from 0 to maximum) of each mode in the space, frequency, time, patient, and stroke-stage dimensions (from left to right), limited here to A and ESA. (B and C). The results of the same decomposition, run separately on the A and LSA stages (B) and on the ESA and LSA stages (C). The asterisk and colored lines indicate significant effects of the pairwise comparisons of the stroke stages (permutation test, pBonf < .05, see Statistical analysis).

Figure 5.

This image depicts the relationship between brain oscillatory modes, motor impairment, and recovery. (A) shows the PARAFAC decomposition of a five-dimensional tensor in patients who are stable and those who are recovering, with different brain oscillatory modes. (B) illustrates the correlation between the alpha-band mode and motor impairment in the acute stage and motor recovery in the early and late subacute stages, highlighted by the Kendall tau coefficient and Bayesian factors for each comparison.

Links among brain oscillatory modes, motor impairment and motor recovery. (A). PARAFAC decomposition of the 5D tensor in stable (left) and recovering (right) patients. (B) Association between the α-band mode and (a) motor impairment in the acute stage, and (b-c) motor recovery toward the early (b) and late (c) subacute stages. The Kendall rank correlation coefficient (τ) and Bayesian factors (BF10) are indicated for each comparison, and all data are plotted according to their rank.

Modulation of Brain Oscillatory Modes as a Proxy of Motor Recovery

We further explored the modulation across stroke stages by distinguishing patients who actually recovered along the evaluated stroke stages (recovering group) from patients who maintained stable motor functions/impairment since their inclusion at the A stage (stable group, for group definitions please see SM). The 2 groups drastically diverged regarding the modulation across stroke stages. These data indicate that the previously observed modulations were mainly driven by the recovering group, in which the same significant effects were observed between ESA and LSA stages (pBonf < 0.05; Figure 5(A), right), whereas no change was noticeable within the stable group between stroke stages (Figure 5(A), left). This finding was further confirmed when focusing on recovering patients that fulfilled the criterion of minimum clinically important difference (MCID+ patients) for FM-UE-total, 26 in which similar brain mode modulations were observed (see SM & Fig. S6).

Figure 6.

The image illustrates the time course of GABAergic inhibition and its relationship with recovery, showing changes in early and late TMS-induced reactivity, and a decrease in GABAergic activity as a recovery-facilitating functional disinhibition after a stroke.

Time course of GABAergic inhibition and its relationship with recovery. The changes in early TMS-evoked reactivity (as demonstrated in Harquel et al, 22 ) and in late TMS-induced α waves, both most likely correlates of a decrease in GABAergic activity at different spatial scales, represent recovery-facilitating functional disinhibition after the detrimental hyper-inhibitory period in the hyper-acute stage after the stroke. Based on the present findings, this disinhibition occurs in 2 phases: first locally within the ipsilesional motor cortex in the acute to subacute stage, and then more broadly toward the late subacute stage. Such disinhibition fosters structural and functional plasticity that support motor recovery.5,27,28

All tensor decompositions showed variability in the weights of modes among patients, that is, within the 4th dimension. We next aimed to explain the variability among patients in terms of impairment, function, and recovery, by linking this variability with the different modes and their changes (Figure 5(B) & S6). No statistical evidence was found for either a link or an absence of links between 1/f and β-band modes on motor scores (all 1/3 < BF10 < 3) in any of the tested patient cohorts. However, moderate to strong statistical evidence was found for a link between the α-band mode and motor scores in the A stage and its evolution across the ESA and LSA stages in the recovering group. First, patients who exhibited a stronger weight associated with this α-band mode were more impaired in the A stage (Figure 5(B(a)), with lower Fugl-Meyer (FM) hand scores (τ = [−0.09 −0.7], BF10 = 7.3). Broader associations with the α-mode were found in better recovering patients between the A and ESA stages (Figure 5(B(b)), as revealed by a stronger change ratio between the A and ESA stages in the FM hand (τ = [0.22 0.8], BF10 = 91), wrist (τ = [0.05 0.65], BF10 = 3.9), and UE-total scores (τ = [0.07 0.67], BF10 = 5.8) as well as the maximum fist force (τ = [0.07 0.67], BF10 = 5.9). The stronger the patients were associated to this α-band mode, the better they improved at the ESA stage. Finally, a similar association was found in the longer term, with stronger change ratios between the A and LSA stages in scores on the FM hand (τ = [0.2 0.8], BF10 = 56), BnB (τ = [0.08 0.7], BF10 = 6.0) and 9-hole peg tests (τ = [-0.08 -0.7], BF10 = 6.0) (Figure 5(B(c)), indicating that greater changes in the α-band mode were associated with larger improvements in motor functions and thus larger reductions in impairment.

Discussion

In the present study, we report significant longitudinal changes in induced oscillatory activity at the group level, associated with functional motor recovery in a cohort of stroke patients. The results, together with other current work, 22 highlight dynamic changes in correlates of inhibitory (GABAergic) activity toward a recovery-supporting disinhibition toward the late subacute stage (for a schematic summary please see Figure 6).

The evolution of TMS-induced oscillations might be a relevant proxy of functional reorganization and its underlying mechanisms. The longitudinal increase and decrease observed in the 1/f spectral trend and α-band modes respectively, together with the absence of any significant change within the β-band mode, underline the importance of the evolution of the excitatory/inhibitory balance across stroke stages (Figures 3(B) and 4). On the one hand, the 1/f spectral trend is an ubiquitous feature of scalp EEG 29 reflecting non-oscillatory aperiodic neural activity. 30 Whereas less studied than neural oscillations, the observed inter- and intra-subject variability of aperiodic activity has been shown to relate notably to aging 31 and conscious states. 32 Recent work suggested that the spectral trend is modulated by several physiological mechanisms, such as synaptic timescale and excitatory/inhibitory balance.33,34 Accordingly, the observed positive modulation trough time post-stroke may serve as a potential correlate of changes within the excitatory/inhibitory balance, putatively resulting from the initial disinhibition phase that occurs locally over the motor cortex during the acute and early subacute stages. 22 However, there are current limitations in our understanding of the precise origin and nature of the aperiodic activity. 33 In addition, we are examining a TMS-induced phenomenon (rather than a resting-state or a task-related one, as in the previously cited literature). Hence, we cannot determine the precise direction of these changes (regulation or alteration) on the basis of aperiodic component modulation alone. On the other hand, TMS-induced α- and β-band activity has been linked with the GABAergic 13 and glutamatergic 16 systems respectively. Therefore, our results rather pointed to a dominantly GABAergic activity changing compared to glutamatergic activity, as we observed variations in α- but not in β-band. This finding points to the existence of a beneficial disinhibition phase, especially for the patients with the greater recovery (Figures 5 and S6).

Although the exact mechanistic role of α oscillations in brain function remains complex and debated, 35 the α-band modulations found here could be considered a proxy of the dynamic evolution of the intracortical inhibitory system, which has been suggested to sustain motor recovery.5,27 This interpretation is supported by the use of resting-state acquisition, minimizing the influence of known cognitive modulators of α activity, and by prior pharmacological TMS-EEG studies employing similar time-frequency features. 13 Immediately after stroke, during the hyperacute phase, hyperinhibition of the perilesional cortical areas prevents additional tissue damage due to ischemia-induced excitotoxicity.28,36,37 However, the persistence of hyperinhibition over time was correlated with worse motor outcomes,5,28 and pharmacological reduction in GABAergic inhibition led to better recovery in animal models.28,38,39 Further evidence has confirmed this last point by linking better motor recovery with a period of plasticity driven by molecular changes, such as cellular excitability, 40 or by sustained disinhibition during the first weeks poststroke. Moreover, the existence of this beneficial disinhibition stage is also confirmed in the present cohort of patients when specifically studying cortical reactivity. 22 Our results revealed the presence of an abnormally stronger reactivity, as also found in a growing number of studies in stroke and other brain injuries,41 -44 whose reduction turned to be beneficial for recovery.22,45 It was proposed that such acute disruption of reactivity may be signatures of sleep-like cortical dynamics and excessive detrimental inhibition in patients with severe impairment. However, our findings indicated that acute hyperexcitability was underpinned by beneficial intracortical motor disinhibition in mildly affected patients, as assessed via paired-pulse TMS. Overall, such disinhibition, whether demonstrated by a reduction in sleep-like cortical dynamics or by assessing intracortical inhibition on the motor system, has been suggested to promote functional reorganization within the lesioned hemisphere.5,27,28 Consistent with this suggestion, the decrease in the α-band mode in the recovering patient group is most likely a correlate of the disinhibition toward the late subacute stage (3 weeks to 3 months poststroke), which supports the recovery process (please see Figure 6 for a schematic). While the existence of such a GABA-mediated disinhibition phase occurring in the subacute stage is in line with previous work (see Paparella et al 46 for a recent review), its exact time frame remains to be elucidated. Its study is made complex by the 2-fold role of GABA post-stroke: while increased inhibition is protective against excitotoxicity, decreased inhibition supports plasticity.4,46

The disinhibition time frame observed here is somewhat delayed compared with our findings regarding brain reactivity on the present cohort 22 and the previous findings of Liuzzi et al, 5 in which disinhibition occurred from the first days to up to 3 weeks after stroke onset. The slight differences in the precise timing of this effect might stem from the brain areas and networks represented by the specific measures and temporal windows from which they are extracted. The electrical activation of neuronal populations subsequent to the TMS pulse is first spatially restricted to the targeted cortical site, before propagating along white matter pathways to reach distant cortical and subcortical sites (see, e.g., Momi et al 47 ). Then, while the short-interval intracortical inhibition protocol used in our study 22 and by Liuzzi et al 5 allows measurement of the intracortical GABAergic activity locally within the motor cortex, the late induced α oscillations in the present work are linked with inhibitory activity at a more global scale, that is, engaged in higher-order processes within larger-scale brain networks (Figure 6). The bottom-up propagation of TMS has been well established. 48 While the stimulation is first triggering local activity within local nodes, it is then propagating to connected brain networks including hubs, such propagation being reflected in the temporality of the EEG signal, from early to late activity.47,48 If the observed timing (later than 400 ms after simulation) and topography of the late induced α oscillations mode are arguments supporting such a broader effect, the present data cannot rule out a potential rebound of local activity within the ipsilesional motor cortex. Thus, the disinhibition phenomenon might first occur locally within the lesioned motor cortex in the acute to subacute stage before spreading to larger brain networks including hubs to promote functional plasticity more broadly and thus support more complex motor functions in later stages, as revealed here by the later association with improvement in complex motor tasks such as the BnB or 9HP.

Limitations

Recent guidelines about TMS-EEG acquisition and data processing were followed in this work, with the exception of the presence of a realistic sham stimulation condition in order to assess the influence of peripheral evoked potentials, due to the multisensory features of TMS, on the recorded EEG signal. 49 However, the present work is based on TMS-induced oscillations, which are computed after removing such evoked components from the signal, and on a longitudinal analysis approach. Thus, the lack of a sham stimulation condition might not have significantly affected the interpretation of the results, even though auditory and somatosensory confounds cannot be entirely ruled out, given their potential influence in the α frequency range as well. In addition, the distribution of the patient cohort with respect to the severity of motor impairment in the acute stage was rather on the moderately to mildly impaired side. Additional analyses of more heterogeneous groups in the future will help to refine the present conclusions regarding the link between changes in brain oscillatory modes and motor recovery. The analysis framework chosen here, based on the classification of hemispheres with respect to lesion presence, concealed effects related to dominant vs. nondominant lesion.

Moreover, the relevant number of session withdrawals of patients due to different reasons (especially COVID-19 pandemic and protocol complexity) precluded the possibility of performing PARAFAC decomposition on the entire cohort of 66 patients longitudinally. As a result, the sample sizes supporting the observed longitudinal modulations and their relationship to motor scales in the recovering group, notably in the FM-UE-based MCID+ patients group, were significantly dampened and limits the scope of our results. However, while FM-UE is widely accepted as a standardized scale for assessing motor impairment, it is prone to a ceiling effect and its granularity becomes limited when it comes to distal skills and function despite their importance for daily life. 50 FM-UE is then best used in combination with the complementary motor assessments performed in our study (BnB and 9HP tasks), for which our MCID patients were still improving, despite presenting very high acute FM-UE scores (above 55). In order to address this limitation and include as many patients as possible within the analytical framework, the 4 potential combinations of stroke stages were systematically investigated. The final interpretation and clinical relevance of the present findings are supported by the consistency of the results obtained by the different analyses.

Finally, the PARAFAC analysis framework allows only to reveal main trends of stroke-related changes in brain oscillatory activity at the group level, and prevents direct inference of physiological changes at the individual level. Consequently, the present results do not allow conclusions to be drawn about the exact magnitude of the observed relationship, that is, between the exact magnitude of the decrease in α power and the extent of motor recovery (e.g., in FM-UE points). To validate the potential of late TMS-induced α activity as a marker and predictor for motor recovery, further investigations based on individual time-frequency maps are needed. A potential first approach would be to individually extract the TMS-induced α power within a spatiotemporal cluster defined by the topography (parieto-occipital area) and the time profile (>400 ms) of the observed TMS-induced α modes. The predictive value of this feature, either at the acute stage or in its modulation toward the subacute stage, could then be assessed using machine learning approaches on large multicentric and longitudinal TMS-EEG datasets. Given the relatively high SNR of slow waves in scalp EEG, another exploratory approach would be to attempt decomposition at the individual level to extract a personalized spatiotemporal cluster for TMS-induced α power extraction, using single trials as observations.

Conclusions

In summary, the combined results of both studies support cortical disinhibition with different topographies and temporal course as an important underlying mechanism driving motor recovery between the early and late subacute stages. Further investigations based on the individual evolution of TMS-induced α oscillations might pave the way for developing biomarkers to determine and predict stroke recovery and to personalize innovative therapies based on modulation of brain oscillatory activity through noninvasive or invasive brain stimulation technologies.

Supplemental Material

sj-pdf-1-nnr-10.1177_15459683251363241 – Supplemental material for Brain Oscillatory Modes as a Proxy of Stroke Recovery

Supplemental material, sj-pdf-1-nnr-10.1177_15459683251363241 for Brain Oscillatory Modes as a Proxy of Stroke Recovery by Sylvain Harquel, Andéol Cadic-Melchior, Takuya Morishita, Lisa Fleury, Martino Ceroni, Pauline Menoud, Julia Brügger, Elena Beanato, Nathalie H. Meyer, Giorgia G. Evangelista, Philip Egger, Dimitri Van de Ville, Olaf Blanke, Silvestro Micera, Bertrand Léger, Jan Adolphsen, Caroline Jagella, Andreas Mühl, Christophe Constantin, Vincent Alvarez, Philippe Vuadens, Jean-Luc Turlan, Christophe Bonvin, Philipp J. Koch, Maximilian J. Wessel and Friedhelm C. Hummel in Neurorehabilitation and Neural Repair

Acknowledgments

We thank the MRI and neuromodulation facilities of the Human Neuroscience Platform of the Fondation Campus Biotech Geneva and the Neuroimaging Center of the Sion Hospital and the Center for Biomedical Imaging, a Swiss research center of excellence, for their expertise and access to their facilities.

Footnotes

Author Contributions: Sylvain Harquel: Conceptualization; Formal analysis; Investigation; Methodology; Visualization; Writing – original draft.

Andéol Cadic-Melchior: Conceptualization; Formal analysis; Investigation; Methodology; Visualization; Writing – review & editing.

Takuya Morishita: Conceptualization; Investigation; Methodology; Project administration; Supervision.

Lisa Fleury: Investigation; Writing – review & editing.

Martino Ceroni: Investigation; Writing – review & editing.

Pauline Menoud: Investigation; Writing – review & editing.

Julia Brügger: Investigation; Writing – review & editing.

Elena Beanato: Investigation; Writing – review & editing.

Nathalie H. Meyer: Investigation; Writing – review & editing.

Giorgia G. Evangelista: Conceptualization; Writing – review & editing.

Philip Egger: Conceptualization; Writing – review & editing.

Dimitri Van De Ville: Conceptualization; Funding acquisition; Writing – review & editing.

Olaf Blanke: Conceptualization; Funding acquisition; Writing – review & editing.

Silvestro Micera: Conceptualization; Funding acquisition; Writing – review & editing.

Bertrand Léger: Investigation; Writing – review & editing.

Jan Adolphsen: Investigation; Writing – review & editing.

Caroline Jagella: Investigation; Writing – review & editing.

Andreas Mühl: Investigation; Writing – review & editing.

Christophe Constantin: Investigation; Writing – review & editing.

Vincent Alvarez: Investigation; Writing – review & editing.

Philippe Vuadens: Investigation; Writing – review & editing.

Jean-Luc Turlan: Investigation; Writing – review & editing.

Christophe Bonvin: Investigation; Writing – review & editing.

Philipp J. Koch: Conceptualization; Investigation; Project administration; Supervision; Writing – review & editing.

Maximilian J. Wessel: Conceptualization; Investigation; Methodology; Project administration; Supervision; Writing – review & editing.

Friedhelm C. Hummel: Conceptualization; Funding acquisition; Methodology; Project administration; Supervision; Writing – review & editing.

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Hummel serves as a board member for Novartis Foundation for Medical-Biological Research. Dr Blanke is a cofounder and a shareholder of Metaphysiks Engineering Société Anonyme, a company that develops immersive technologies, including applications of the robotic induction of presence hallucinations that are not related to the diagnosis, prognosis, or treatment in medicine. Dr Blanke is a member of the board and a shareholder of Mindmaze Société Anonyme.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the “Personalized Health and Related Technologies (PHRT-#2017-205)” of the ETH Domain (CH), the Defitech Foundation (Strike-the-Stroke project, Morges, CH), the SNSF (NIBS-iCog, 320030L_197899/1) and the Wyss Center for Bio- and Neuroengineering (WP030; Geneva, CH).

ORCID iDs: Sylvain Harquel Inline graphic https://orcid.org/0000-0001-8756-2230

Friedhelm C. Hummel Inline graphic https://orcid.org/0000-0002-4746-4633

Supplementary material for this article is available on the Neurorehabilitation & Neural Repair website along with the online version of this article.

References

  • 1. Grefkes C, Fink GR. Recovery from stroke: current concepts and future perspectives. Neurol Res Pract. 2020;2:17. doi: 10.1186/s42466-020-00060-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Micera S, Caleo M, Chisari C, Hummel FC, Pedrocchi A. Advanced neurotechnologies for the restoration of motor function. Neuron. 2020;105:604-620. doi: 10.1016/j.neuron.2020.01.039 [DOI] [PubMed] [Google Scholar]
  • 3. Cirillo J, Mooney RA, Ackerley SJ, et al. Neurochemical balance and inhibition at the subacute stage after stroke. J Neurophysiol. 2020;123:1775-1790. doi: 10.1152/jn.00561.2019 [DOI] [PubMed] [Google Scholar]
  • 4. Carmichael ST. Brain excitability in stroke: the yin and yang of stroke progression. Arch Neurol. 2012;69:161-167. doi: 10.1001/archneurol.2011.1175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Liuzzi G, Hörniß V, Lechner P, et al. Development of movement-related intracortical inhibition in acute to chronic subcortical stroke. Neurology. 2014;82:198-205. doi: 10.1212/WNL.0000000000000028 [DOI] [PubMed] [Google Scholar]
  • 6. Blicher JU, Near J, Næss-Schmidt E, et al. GABA levels are decreased after stroke and GABA changes during rehabilitation correlate with motor improvement. Neurorehabil Neural Repair. 2015;29:278-286. doi: 10.1177/1545968314543652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Hernandez-Pavon JC, Veniero D, Bergmann TO, et al. TMS combined with EEG: recommendations and open issues for data collection and analysis. Brain Stimul. 2023;16(2):567-593. doi: 10.1016/j.brs.2023.02.009. [DOI] [PubMed] [Google Scholar]
  • 8. Passera B, Chauvin A, Raffin E, Bougerol T, David O, Harquel S. Exploring the spatial resolution of TMS-EEG coupling on the sensorimotor region. NeuroImage. 2022;259:119419. doi: 10.1016/j.neuroimage.2022.119419 [DOI] [PubMed] [Google Scholar]
  • 9. Pellicciari MC, Veniero D, Miniussi C. Characterizing the cortical oscillatory response to TMS pulse. Front Cell Neurosci. 2017;11:38. doi: 10.3389/fncel.2017.00038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Harquel S, Bacle T, Beynel L, Marendaz C, Chauvin A, David O. Mapping dynamical properties of cortical microcircuits using robotized TMS and EEG: towards functional cytoarchitectonics. Neuroimage. 2016;135:115-124. doi: 10.1016/j.neuroimage.2016.05.009 [DOI] [PubMed] [Google Scholar]
  • 11. Rosanova M, Casali A, Bellina V, Resta F, Mariotti M, Massimini M. Natural frequencies of human corticothalamic circuits. J Neurosci. 2009;29:7679-7685. doi: 10.1523/JNEUROSCI.0445-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Mutanen T. TMS-evoked changes in brain-state dynamics quantified by using EEG data. Front Hum Neurosci. 2013;7:155. doi: 10.3389/fnhum.2013.00155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Premoli I, Bergmann TO, Fecchio M, et al. The impact of GABAergic drugs on TMS-induced brain oscillations in human motor cortex. NeuroImage. 2017;163:1-12. doi: 10.1016/j.neuroimage.2017.09.023. [DOI] [PubMed] [Google Scholar]
  • 14. Harshman RA. Foundations of the PARAFAC procedure: models and conditions for an “explanatory” multimodal factor analysis. UCLA Work Pap Phonetics. 1970;16:1-84. [Google Scholar]
  • 15. Tangwiriyasakul C, Premoli I, Spyrou L, Chin RF, Escudero J, Richardson MP. Tensor decomposition of TMS-induced EEG oscillations reveals data-driven profiles of antiepileptic drug effects. Sci Rep. 2019;9:17057. doi: 10.1038/s41598-019-53565-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Belardinelli P, König F, Liang C, et al. TMS-EEG signatures of glutamatergic neurotransmission in human cortex. Sci Rep. 2021;11:8159. doi: 10.1038/s41598-021-87533-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Hummel F, Andres F, Altenmüller E, Dichgans J, Gerloff C. Inhibitory control of acquired motor programmes in the human brain. Brain. 2002;125:404-420. doi: 10.1093/brain/awf030 [DOI] [PubMed] [Google Scholar]
  • 18. Jensen O, Mazaheri A. Shaping functional architecture by oscillatory alpha activity: gating by inhibition. Front Hum Neurosci. 2010;4:186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Klimesch W, Sauseng P, Hanslmayr S. EEG alpha oscillations: the inhibition-timing hypothesis. Brain Res Rev. 2007;53:63-88. doi: 10.1016/j.brainresrev.2006.06.003 [DOI] [PubMed] [Google Scholar]
  • 20. Thut G, Nietzel A, Brandt SA, Pascual-Leone A. Alpha-band electroencephalographic activity over occipital cortex indexes visuospatial attention bias and predicts visual target detection. J Neurosci. 2006;26:9494-9502. doi: 10.1523/JNEUROSCI.0875-06.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Fleury L, Koch PJ, Wessel MJ, et al. Towards individualized Medicine in Stroke: the TiMeS project: protocol of longitudinal, multi-modal, multi-domain study in stroke. Front Neurol. 2022;13:939640. doi: 10.1101/2022.05.18.22274612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Harquel S, Cadic-Melchior A, Morishita T, et al. Stroke recovery–related changes in cortical reactivity based on modulation of intracortical inhibition. Stroke. 2024;55(6):1629-1640. doi: 10.1161/STROKEAHA.123.045174 [DOI] [PubMed] [Google Scholar]
  • 23. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP;, STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453-1457. doi: 10.1016/S0140-6736(07)61602-X [DOI] [PubMed] [Google Scholar]
  • 24. Oostenveld R, Fries P, Maris E, Schoffelen J-M. FieldTrip: open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data. Comput Intell Neurosci. 2011;2011:1-9. doi: 10.1155/2011/156869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Jeffreys H. The Theory of Probability. OUP Oxford; 1998. [Google Scholar]
  • 26. Page SJ, Fulk GD, Boyne P. Clinically important differences for the upper-extremity Fugl-Meyer Scale in people with minimal to moderate impairment due to chronic stroke. Phys Ther. 2012;92:791-798. doi: 10.2522/ptj.20110009 [DOI] [PubMed] [Google Scholar]
  • 27. Mooney RA, Ackerley SJ, Rajeswaran DK, et al. The influence of primary motor cortex inhibition on upper limb impairment and function in chronic stroke: a multimodal study. Neurorehabil Neural Repair. 2019;33:130-140. doi: 10.1177/1545968319826052 [DOI] [PubMed] [Google Scholar]
  • 28. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010;468:305-309. doi: 10.1038/nature09511 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Pritchard WS. The brain in fractal time: 1/F-like power spectrum scaling of the human electroencephalogram. Int J Neurosci. 1992;66:119-129. doi: 10.3109/00207459208999796 [DOI] [PubMed] [Google Scholar]
  • 30. Donoghue T, Schaworonkow N, Voytek B. Methodological considerations for studying neural oscillations. Eur J Neurosci. 2022;55:3502-3527. doi: 10.1111/ejn.15361 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Voytek B, Kramer MA, Case J, et al. Age-related changes in 1/f neural electrophysiological noise. J Neurosci. 2015;35:13257-13265. doi: 10.1523/JNEUROSCI.2332-14.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Colombo MA, Napolitani M, Boly M, et al. The spectral exponent of the resting EEG indexes the presence of consciousness during unresponsiveness induced by propofol, xenon, and ketamine. NeuroImage. 2019;189:631-644. doi: 10.1016/j.neuroimage.2019.01.024 [DOI] [PubMed] [Google Scholar]
  • 33. Brake N, Duc F, Rokos A, et al. A neurophysiological basis for aperiodic EEG and the background spectral trend. Nat Commun. 2024;15:1514. doi: 10.1038/s41467-024-45922-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Gao R, Peterson EJ, Voytek B. Inferring synaptic excitation/inhibition balance from field potentials. NeuroImage. 2017;158:70-78. doi: 10.1016/j.neuroimage.2017.06.078 [DOI] [PubMed] [Google Scholar]
  • 35. Sadaghiani S, Kleinschmidt A. Brain networks and α-oscillations: structural and functional foundations of cognitive control. Trends Cogn Sci. 2016;20:805-817. [DOI] [PubMed] [Google Scholar]
  • 36. Michalettos G, Ruscher K. Crosstalk between GABAergic neurotransmission and inflammatory cascades in the post-ischemic brain: relevance for stroke recovery. Front Cell Neurosci. 2022;16:807911. doi: 10.3389/fncel.2022.807911 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Rabiller G, He JW, Nishijima Y, Wong A, Liu J. Perturbation of brain oscillations after ischemic stroke: a potential biomarker for post-stroke function and therapy. Int J Mol Sci. 2015;16:25605. doi: 10.3390/ijms161025605 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Lamtahri R, Hazime M, Gowing EK, et al. The Gliopeptide ODN, a ligand for the benzodiazepine site of GABAA receptors, boosts functional recovery after stroke. J Neurosci. 2021;41:7148-7159. doi: 10.1523/JNEUROSCI.2255-20.2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Lebrun F, Violle N, Letourneur A, et al. Post-acute delivery of α5-GABAA antagonist, S 44819, improves functional recovery in juvenile rats following stroke. Exp Neurol. 2022;347:113881. doi: 10.1016/j.expneurol.2021.113881 [DOI] [PubMed] [Google Scholar]
  • 40. Joy MT, Carmichael ST. Encouraging an excitable brain state: mechanisms of brain repair in stroke. Nat Rev Neurosci. 2021;22:38-53. doi: 10.1038/s41583-020-00396-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Massimini M, Corbetta M, Sanchez-Vives MV, et al. Sleep-like cortical dynamics during wakefulness and their network effects following brain injury. Nat Commun. 2024;15:7207. doi: 10.1038/s41467-024-51586-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Tscherpel C, Dern S, Hensel L, Ziemann U, Fink GR, Grefkes C. Brain responsivity provides an individual readout for motor recovery after stroke. Brain. 2020;143:1873-1888. doi: 10.1093/brain/awaa127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Tscherpel C, Mustin M, Massimini M, et al. Local neuronal sleep after stroke: the role of cortical bistability in brain reorganization. Brain Stimul. 2024;17:836-846. doi: 10.1016/j.brs.2024.07.008 [DOI] [PubMed] [Google Scholar]
  • 44. Bai Z, Zhang JJ, Fong KNK. Intracortical and intercortical networks in patients after stroke: a concurrent TMS-EEG study. J Neuroeng Rehabil. 2023;20:100. doi: 10.1186/s12984-023-01223-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Sarasso S, D’Ambrosio S, Russo S, et al. Reduction of sleep-like perilesional slow waves and clinical evolution after stroke: a TMS-EEG study. Clin Neurophysiol. 2025;175:2110746. doi: 10.1016/j.clinph.2025.2110746 [DOI] [PubMed] [Google Scholar]
  • 46. Paparella I, Vanderwalle G, Stagg CJ, Maquet P. An integrated measure of GABA to characterize post-stroke plasticity. Neuroimage Clin. 2023;39:103463. doi: 10.1016/j.nicl.2023.103463 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Momi D, Wang Z, Griffiths JD. TMS-evoked responses are driven by recurrent large-scale network dynamics. eLife. 2023;12:e83232. doi: 10.7554/eLife.83232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Bortoletto M, Veniero D, Thut G, Miniussi C. The contribution of TMS–EEG coregistration in the exploration of the human cortical connectome. Neurosci Biobehav Rev. 2015;49:114-124. doi: 10.1016/j.neubiorev.2014.12.014 [DOI] [PubMed] [Google Scholar]
  • 49. Conde V, Tomasevic L, Akopian I, et al. The non-transcranial TMS-evoked potential is an inherent source of ambiguity in TMS-EEG studies. NeuroImage. 2019;185:300-312. doi: 10.1016/j.neuroimage.2018.10.052 [DOI] [PubMed] [Google Scholar]
  • 50. Santisteban L, Térémetz M, Bleton J-P, et al. Upper limb outcome measures used in stroke rehabilitation studies: a systematic literature review. PLoS ONE. 2016;11:e0154792. doi: 10.1371/journal.pone.0154792 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

sj-pdf-1-nnr-10.1177_15459683251363241 – Supplemental material for Brain Oscillatory Modes as a Proxy of Stroke Recovery

Supplemental material, sj-pdf-1-nnr-10.1177_15459683251363241 for Brain Oscillatory Modes as a Proxy of Stroke Recovery by Sylvain Harquel, Andéol Cadic-Melchior, Takuya Morishita, Lisa Fleury, Martino Ceroni, Pauline Menoud, Julia Brügger, Elena Beanato, Nathalie H. Meyer, Giorgia G. Evangelista, Philip Egger, Dimitri Van de Ville, Olaf Blanke, Silvestro Micera, Bertrand Léger, Jan Adolphsen, Caroline Jagella, Andreas Mühl, Christophe Constantin, Vincent Alvarez, Philippe Vuadens, Jean-Luc Turlan, Christophe Bonvin, Philipp J. Koch, Maximilian J. Wessel and Friedhelm C. Hummel in Neurorehabilitation and Neural Repair


Articles from Neurorehabilitation and Neural Repair are provided here courtesy of SAGE Publications

RESOURCES